Targeting Host Nucleotide Biosynthesis With Resveratrol Inhibits Emtricitabine-Resistant HIV-1

AIDS - United States
doi 10.1097/qad.0000000000000168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

CXCR7/ACKR3-targeting Ligands Interfere With X7 HIV-1 and HIV-2 Entry and Replication in Human Host Cells

Heliyon
Multidisciplinary
2018English

Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

New England Journal of Medicine
Medicine
2009English

Lack of Synergy for Inhibitors Targeting a Multi-Drug Resistant Hiv-1 Protease

2002English

Resveratrol Inhibits Proliferation and Promotes Apoptosis of Keloid Fibroblasts by Targeting HIF-1α

Journal of Clinical & Experimental Dermatology Research
2017English

Viral Protein U Counteracts a Human Host Cell Restriction That Inhibits HIV-1 Particle Production

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses

Frontiers in Oncology
Cancer ResearchOncology
2017English

Dynamins Are Forever: MxB Inhibits HIV-1

Cell Host and Microbe
ImmunologyMolecular BiologyCancer ResearchVirologyMicrobiologyMicrobiology Parasitology
2013English

Raltegravir With Optimized Background Therapy for Resistant HIV-1 Infection

New England Journal of Medicine
Medicine
2008English

HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated With Clinical Disease Severity

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy